Hence, the chemical suppression of both SIRT3- and NRF2-dependent signaling pathways is currently seen as an effective means by which cancer cells could be sensitized to chemo- and radio-therapy37, 39, 80. The gene discussed is NFE2L2; the disease is cancer.